Atlanta (June 16 2025)-- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray technology, is now ...

In response, researchers have developed HiTIP-seq, a microarray-based high-throughput in situ tagged immunoprecipitation sequencing technology.

About Micron Biomedical Micron Biomedical is the leader in dissolvable microarray-based, drug and vaccine administration technology.

Courtesy of CombiMatrix The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading ...